Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine.

Source:http://linkedlifedata.com/resource/pubmed/id/17436227

J. Infect. Dis. 2007 May 15 195 10 1472-9

Download in:

View as

General Info

PMID
17436227